Director/PDMR Shareholding

RNS Number : 8550W

GlaxoSmithKline PLC

03 January 2014

 



Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc (the Company).

On 31 December 2013, the Company's Non-Executive Directors were provisionally allocated the following awards over Ordinary Shares and ADSs in the Company through the annual reinvestment of dividends paid throughout 2013; calculated using an average price of £16.07 per Ordinary Share and $53.17 per ADS:

Non-Executive Director	Ordinary Shares	No. of ADSs
Sir Christopher Gent	4,354.409
Prof Sir Roy Anderson	675.908
Dr Stephanie Burns		528.928
Stacey Cartwright	125.486
Lynn Elsenhans		62.813
Judy Lewent		80.699
Sir Deryck Maughan		1,343.402
Dr Daniel Podolsky		951.863
Tom de Swaan	980.751
Jing Ulrich		19.485
Hans Wijers	3.631
Sir Robert Wilson	1,485.756

The Company and the Non-Executive Directors were informed of these allocations on 2 January 2014.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

Sonja Arsenić 

Corporate Secretariat

3 January 2014

 

END

 

 

RDSKXLBBZFFXBBK